IntraBiotics acquired Apothogen in a stock transaction worth up to US$1.8 M. Dr Mario, Chairman and CEO of IntraBiotics purchased US$5 M worth of IntraBiotics common stock in a private placement concurrent with the acquisition of Apothogen.